This Eurostars grant is a major milestone for VERIGRAFT and regenerative medicine. With PREPPER, we are accelerating the future of personalized tissue therapies,” said Dr. Raimund Strehl, CTO of ...

The immune protein STAT6 may be a driver of pulmonary hypertension in people with obstructive sleep apnea, a study in mice ...

Researchers investigated cerebral small vessel disease, a precursor to dementia, by analyzing data from thousands of ...

A study reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid ...

LeMaitre Vascular, Inc. (NASDAQ: LMAT) announced in a recent 8-K filing its decision to appoint Dorian LeBlanc as the company’s Chief Financial Officer. LeBlanc, age 50, will assume the role effective ...

A study reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid beta -- a hallmark of Alzheimer's disease. The findings suggest that vascular ...

VERIGRAFT receives €1.2 million to 3D print arterial grafts - aiming to create customized vascular grafts that mimic natural arteries.

LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) has earned an average rating of “Moderate Buy” from the nine research firms that are currently covering the company, Ratings reports. Two ...

Scientists from CNRS, in collaboration with hospital-university practitioners, veterinarians, and academics, have developed ...

A study at Lund University reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid beta—a hallmark of Alzheimer's disease. The findings ...

Humacyte has priced the product at $29,500 per unit. This is more expensive than the synthetic vessels already on the market.